{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:44:26Z","timestamp":1782747866786,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Pfizer Medical"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00284-026-04960-9","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:29:12Z","timestamp":1780554552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the Genetic Mechanisms Driving Carbapenem Resistance: A Multicenter Study from Seven Egyptian Governorates Using Multiplex PCR and Whole Genome Sequencing"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-6747","authenticated-orcid":false,"given":"Maha","family":"Gad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Essam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas","family":"El-Defrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdelhakeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shoala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamida","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadir","family":"El-Mahallawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"El-kholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4960_CR1","doi-asserted-by":"publisher","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z et al (2023) Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res 266:127249. https:\/\/doi.org\/10.1016\/j.micres.2022.127249","journal-title":"Microbiol Res"},{"key":"4960_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y (2017) The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:460\u2013469","journal-title":"Virulence"},{"key":"4960_CR3","volume-title":"Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO) (2017) Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. WHO, Geneva, Switzerland. [accessed 14 December 2023]https:\/\/www.who.int\/medicines\/areas\/rational_use\/prioritization-of-pathogens\/en"},{"issue":"Suppl 7","key":"4960_CR4","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y (2019) Treatment options for carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis 69(Suppl 7):S565\u2013S575. https:\/\/doi.org\/10.1093\/cid\/ciz830","journal-title":"Clin Infect Dis"},{"key":"4960_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","volume":"22","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang J, Wang R, Cai Y (2020) Resistance to ceftazidime-avibactam and underlying mechanisms. J Glob Antimicrob Resist 22:18\u201327. https:\/\/doi.org\/10.1016\/j.jgar.2019.12.009","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"4960_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1086\/673985","volume":"34","author":"I See","year":"2013","unstructured":"See I, Lessa FC, ElAta OA, Hafez S, Samy K, El-Kholy A et al (2013) Incidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt. Infect Control Hosp Epidemiol 34(12):1281\u20131288. https:\/\/doi.org\/10.1086\/673985","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"4960_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ajic.2016.04.212","volume":"44","author":"M Talaat","year":"2016","unstructured":"Talaat M, El-Shokry M, El-Kholy J, Ismail G, Kotb S, Hafez S et al (2016) National surveillance of health care\u2013associated infections in Egypt: developing a sustainable program in a resource-limited country. Am J Infect Control 44(11):1296\u20131301. https:\/\/doi.org\/10.1016\/j.ajic.2016.04.212","journal-title":"Am J Infect Control"},{"key":"4960_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2147\/IDR.S298920","volume":"14","author":"A El-Kholy","year":"2021","unstructured":"El-Kholy A, El-Mahallawy HA, Elsharnouby N, Aziz A, Helmy M, Kotb AM (2021) Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review. Infect Drug Resist 14:1905\u20131920. https:\/\/doi.org\/10.2147\/IDR.S298920","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4960_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"66","author":"D van Duin","year":"2018","unstructured":"van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Antibacterial Resistance Leadership Group et al (2018) Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 66(2):163\u2013171. https:\/\/doi.org\/10.1093\/cid\/cix783","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4960_CR10","doi-asserted-by":"publisher","first-page":"e01076","DOI":"10.1128\/AAC.01076-18","volume":"62","author":"K Bush","year":"2018","unstructured":"Bush K (2018) Past and present perspectives on \u00df-lactamases. Antimicrob Agents Chemother 62(10):e01076\u2013e01018. https:\/\/doi.org\/10.1128\/AAC.01076-18","journal-title":"Antimicrob Agents Chemother"},{"key":"4960_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2021.05.079","volume":"109","author":"HA Hakeam","year":"2021","unstructured":"Hakeam HA, Alsahli H, Albabtain L, Alassaf S, Al Duhailib Z, Althawadi S (2021) Effectiveness of ceftazidime-avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia. Int J Infect Dis 109:1\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2021.05.079","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4960_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12962-023-00454-8","volume":"21","author":"Z Goudarzi","year":"2023","unstructured":"Goudarzi Z, Danayi F, Keshavarz K, Gholami A (2023) Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran. Cost Eff Resour Alloc 21(1):45. https:\/\/doi.org\/10.1186\/s12962-023-00454-8","journal-title":"Cost Eff Resour Alloc"},{"issue":"6","key":"4960_CR13","doi-asserted-by":"publisher","first-page":"e1571","DOI":"10.1002\/wsbm.1571","volume":"14","author":"L Xiong","year":"2022","unstructured":"Xiong L, Wang X, Wang Y, Yu W, Zhou Y, Chi X et al (2022) Molecular mechanisms underlying bacterial resistance to ceftazidime\/avibactam. WIREs Mech Dis 14(6):e1571. https:\/\/doi.org\/10.1002\/wsbm.1571","journal-title":"WIREs Mech Dis"},{"issue":"3","key":"4960_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1128\/AAC.01585-15","volume":"60","author":"JM Pag\u00e8s","year":"2015","unstructured":"Pag\u00e8s JM, Peslier S, Keating TA, Lavigne JP, Nichols WW (2015) Role of the outer membrane and porins in susceptibility of \u03b2-Lactamase-producing Enterobacteriaceae to Ceftazidime-Avibactam. Antimicrob Agents Chemother 60(3):1349\u20131359. https:\/\/doi.org\/10.1128\/AAC.01585-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4960_CR15","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/jac\/dkx066","volume":"72","author":"Z Shen","year":"2017","unstructured":"Shen Z, Ding B, Ye M, Wang P, Bi Y, Wu S et al (2017) High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime\/avibactam in KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 72(7):1930\u20131936. https:\/\/doi.org\/10.1093\/jac\/dkx066","journal-title":"J Antimicrob Chemother"},{"key":"4960_CR16","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2021) Performance standards for antimicrobial susceptibility testing. CLSI document, M100-31th ed. Wayne, PA, USA"},{"issue":"1","key":"4960_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70(1):119\u2013123. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"4960_CR18","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1128\/JCM.06094-11","volume":"50","author":"MV Larsen","year":"2012","unstructured":"Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL et al (2012) Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50(4):1355\u20131361. https:\/\/doi.org\/10.1128\/JCM.06094-11","journal-title":"J Clin Microbiol"},{"issue":"12","key":"4960_CR19","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","volume":"75","author":"V Bortolaia","year":"2020","unstructured":"Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V et al (2020) ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother 75(12):3491\u20133500. https:\/\/doi.org\/10.1093\/jac\/dkaa345","journal-title":"J Antimicrob Chemother"},{"key":"4960_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00197-18","author":"RR Wick","year":"2018","unstructured":"Wick RR, Heinz E, Holt KE, Wyres KL (2018) Kaptive web: user-friendly capsule and lipopolysaccharide serotype prediction for Klebsiella genomes. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00197-18","journal-title":"J Clin Microbiol"},{"issue":"3","key":"4960_CR21","doi-asserted-by":"publisher","first-page":"000800","DOI":"10.1099\/mgen.0.000800","volume":"8","author":"MMC Lam","year":"2022","unstructured":"Lam MMC, Wick RR, Judd LM, Holt KE, Wyres KL (2022) Kaptive 2.0: updated capsule and lipopolysaccharide locus typing for the Klebsiella pneumoniae species complex. Microb Genom 8(3):000800. https:\/\/doi.org\/10.1099\/mgen.0.000800","journal-title":"Microb Genom"},{"issue":"W1","key":"4960_CR22","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkw290","volume":"44","author":"I Letunic","year":"2016","unstructured":"Letunic I, Bork P (2016) Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 44(W1):W242\u2013W245. https:\/\/doi.org\/10.1093\/nar\/gkw290","journal-title":"Nucleic Acids Res"},{"key":"4960_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jgar.2021.08.010","volume":"27","author":"P Kiratisin","year":"2021","unstructured":"Kiratisin P, Kazmierczak K, Stone GG (2021) In vitro activity of ceftazidime\/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018. J Glob Antimicrob Resist 27:132\u2013141. https:\/\/doi.org\/10.1016\/j.jgar.2021.08.010","journal-title":"J Glob Antimicrob Resist"},{"issue":"7","key":"4960_CR24","doi-asserted-by":"publisher","first-page":"e0200020","DOI":"10.1128\/AAC.02000-20","volume":"65","author":"KM Kazmierczak","year":"2021","unstructured":"Kazmierczak KM, Karlowsky JA, de Jonge BLM, Stone GG, Sahm DF (2021) Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible Enterobacterales collected as part of a global surveillance program, 2012 to 2017. Antimicrob Agents Chemother 65(7):e0200020. https:\/\/doi.org\/10.1128\/AAC.02000-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4960_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13756-019-0639-7","volume":"9","author":"S Kotb","year":"2020","unstructured":"Kotb S, Lyman M, Ismail G, Abd El Fattah M, Girgis SA, Etman A et al (2020) Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011\u20132017. Antimicrob Resist Infect Control 9(1):2. https:\/\/doi.org\/10.1186\/s13756-019-0639-7","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4960_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42506-023-001348","volume":"98","author":"N Mohamed","year":"2023","unstructured":"Mohamed N, Ghazal A, Ahmed AAH, Zaki A (2023) Prevalence and determinants of antimicrobial resistance of pathogens isolated from cancer patients in an intensive care unit in Alexandria, Egypt. J Egypt Public Health Assoc 98(1):9. https:\/\/doi.org\/10.1186\/s42506-023-001348","journal-title":"J Egypt Public Health Assoc"},{"key":"4960_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcimb.2020.00314","volume":"10","author":"R Han","year":"2020","unstructured":"Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, China Antimicrobial Surveillance Network (CHINET) Study Group et al (2020) Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated from Adult and Children Patients in China. Front Cell Infect Microbiol 10:31. https:\/\/doi.org\/10.3389\/fcimb.2020.00314","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"4960_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/mdr.2021.0123","volume":"28","author":"LZ Nabti","year":"2022","unstructured":"Nabti LZ, Sahli F, Olowo-Okere A, Benslama A, Harrar A, Lupande-Mwenebitu D et al (2022) Molecular characterization of clinical carbapenem-resistant Enterobacteriaceae isolates from S\u00e9tif, Algeria. Microb Drug Resist 28(3):274\u2013279. https:\/\/doi.org\/10.1089\/mdr.2021.0123","journal-title":"Microb Drug Resist"},{"key":"4960_CR29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/IDR.S455146","volume":"17","author":"J Li","year":"2024","unstructured":"Li J, Wu W, Wu M, Zhou Z, Wang J, Qiu M et al (2024) Clinical and Molecular Characteristics of Patients with Bloodstream Infections Caused by KPC and NDM Co-Producing Carbapenem-Resistant Klebsiella pneumoniae. Infect Drug Resist 17:1685\u20131697. https:\/\/doi.org\/10.2147\/IDR.S455146","journal-title":"Infect Drug Resist"},{"key":"4960_CR30","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2147\/IDR.S400138","volume":"16","author":"F Rong","year":"2023","unstructured":"Rong F, Liu Z, Yang P, Wu F, Sun Y, Sun X et al (2023) Epidemiological and molecular characteristics of blaNDM-1 and blaKPC-2 co-occurrence Carbapenem-Resistant Klebsiella pneumoniae. Infect Drug Resist 16:2247\u20132258. https:\/\/doi.org\/10.2147\/IDR.S400138","journal-title":"Infect Drug Resist"},{"issue":"3","key":"4960_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-019-03761-2","volume":"39","author":"DM Ghaith","year":"2020","unstructured":"Ghaith DM, Zafer MM, Said HM, Elanwary S, Elsaban S, Al-Agamy MH et al (2020) Genetic diversity of carbapenem-resistant Klebsiella Pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt. Eur J Clin Microbiol Infect Dis 39(3):583\u2013591. https:\/\/doi.org\/10.1007\/s10096-019-03761-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"4960_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s40265-018-0902-x","volume":"78","author":"M Shirley","year":"2018","unstructured":"Shirley M (2018) Ceftazidime-Avibactam: a review in the treatment of serious gram-negative bacterial infections. Drugs 78(6):675\u2013692. https:\/\/doi.org\/10.1007\/s40265-018-0902-x","journal-title":"Drugs"},{"key":"4960_CR33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/1471-2180-11-50","volume":"8","author":"YC Lin","year":"2011","unstructured":"Lin YC, Lu MC, Tang HL, Liu HC, Chen CH, Liu KS et al (2011) Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain. BMC Microbiol 8:1150. https:\/\/doi.org\/10.1186\/1471-2180-11-50","journal-title":"BMC Microbiol"},{"issue":"8","key":"4960_CR34","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s10096-021-04185-7","volume":"40","author":"FB Abid","year":"2021","unstructured":"Abid FB, Tsui CKM, Doi Y, Deshmukh A, McElheny CL, Bachman WC et al (2021) Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar. Eur J Clin Microbiol Infect Dis 40(8):1779\u20131785. https:\/\/doi.org\/10.1007\/s10096-021-04185-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"4960_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10096-021-04177-7","volume":"40","author":"M Sherif","year":"2021","unstructured":"Sherif M, Palmieri M, Mirande C, El-Mahallawy H, Rashed HG, Abd-El-Reheem F et al (2021) Whole-genome sequencing of Egyptian multidrug-resistant Klebsiella pneumoniae isolates: a multi-center pilot study. Eur J Clin Microbiol Infect Dis 40(7):1451\u20131460. https:\/\/doi.org\/10.1007\/s10096-021-04177-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4960_CR36","doi-asserted-by":"publisher","first-page":"105583","DOI":"10.1016\/j.meegid.2024.105583","volume":"119","author":"H Diab","year":"2024","unstructured":"Diab H, Rahy K, Jisr T, El Chaar M, Abboud E, Tokajian S (2024) Phenotypic and molecular characterization of multi-drug resistant Klebsiella spp. isolates recovered from clinical settings. Infect Genet Evol 119:105583. https:\/\/doi.org\/10.1016\/j.meegid.2024.105583","journal-title":"Infect Genet Evol"},{"issue":"2","key":"4960_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4269\/ajtmh.22-0168","volume":"108","author":"AC Dikoumba","year":"2022","unstructured":"Dikoumba AC, Onanga R, Jean-Pierre H, Didelot MN, Dumont Y, Ouedraogo AS et al (2022) Prevalence and phenotypic and molecular characterization of carbapenemase-producing gram-negative bacteria in Gabon. Am J Trop Med Hyg 108(2):268\u2013274. https:\/\/doi.org\/10.4269\/ajtmh.22-0168","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"4960_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/antibiotics12030525","volume":"12","author":"AJ Gondal","year":"2023","unstructured":"Gondal AJ, Choudhry N, Bukhari H, Rizvi Z, Jahan S, Yasmin N, Estimation (2023) Evaluation and characterization of carbapenem resistance burden from a tertiary care hospital, Pakistan. Antibiot (Basel) 12(3):525. https:\/\/doi.org\/10.3390\/antibiotics12030525","journal-title":"Antibiot (Basel)"},{"key":"4960_CR39","doi-asserted-by":"publisher","first-page":"765624","DOI":"10.3389\/fpubh.2022.765624","volume":"10","author":"T Wei","year":"2022","unstructured":"Wei T, Zou C, Qin J, Tao J, Yan L, Wang J et al (2022) Emergence of hypervirulent ST11-K64 Klebsiella pneumoniae poses a serious clinical threat in older patients. Front Public Health 10:765624. https:\/\/doi.org\/10.3389\/fpubh.2022.765624","journal-title":"Front Public Health"},{"issue":"1","key":"4960_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1473-3099(17)30489-9","volume":"18","author":"D Gu","year":"2018","unstructured":"Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L et al (2018) A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18(1):37\u201346. https:\/\/doi.org\/10.1016\/S1473-3099(17)30489-9","journal-title":"Lancet Infect Dis"},{"key":"4960_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/IDR.S284455","volume":"14","author":"D Osama","year":"2021","unstructured":"Osama D, El-Mahallawy H, Mansour MT, Hashem A, Attia AS (2021) Molecular Characterization of carbapenemase-producing Klebsiella pneumoniae Isolated from Egyptian pediatric cancer patients including a strain with a rare gene-combination of \u03b2-lactamases. Infect Drug Resist 14:335\u2013348. https:\/\/doi.org\/10.2147\/IDR.S284455","journal-title":"Infect Drug Resist"},{"issue":"1","key":"4960_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3855\/jidc.17168","volume":"17","author":"A Rahmani","year":"2023","unstructured":"Rahmani A, Meradi L, Piris R (2023) Molecular characterization of the whole genome in clinical multidrug-resistant strains of Klebsiella pneumoniae. J Infect Dev Ctries 17(1):59\u201365. https:\/\/doi.org\/10.3855\/jidc.17168","journal-title":"J Infect Dev Ctries"},{"key":"4960_CR43","doi-asserted-by":"publisher","first-page":"1324846","DOI":"10.3389\/fcimb.2023.1324846","volume":"13","author":"L Ma","year":"2024","unstructured":"Ma L, Qu Y, Wang W, Wang D (2024) Characterization of Klebsiella pneumoniae carrying the blaNDM-1 gene in IncX3 plasmids and the rare In1765 in an IncFIB-IncHI1B plasmid. Front Cell Infect Microbiol 13:1324846. https:\/\/doi.org\/10.3389\/fcimb.2023.1324846","journal-title":"Front Cell Infect Microbiol"},{"key":"4960_CR44","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001409","author":"A Al Fadhli","year":"2021","unstructured":"Al Fadhli A, Jamal W, Rotimi VO (2021) Molecular characterization of rectal isolates of carbapenemase-negative carbapenem-resistant enterobacterales obtained from ICU patients in Kuwait by whole-genome sequencing. J Med Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.001409","journal-title":"J Med Microbiol"},{"issue":"5\u20136","key":"4960_CR45","doi-asserted-by":"publisher","first-page":"106679","DOI":"10.1016\/j.ijantimicag.2022.106679","volume":"60","author":"YL Lee","year":"2022","unstructured":"Lee YL, Ko WC, Hsueh PR (2022) Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime\/avibactam, meropenem\/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. Int J Antimicrob Agents 60(5\u20136):106679. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106679","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"4960_CR46","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ijantimicag.2018.03.020","volume":"52","author":"Z Hamzaoui","year":"2018","unstructured":"Hamzaoui Z, Ocampo-Sosa A, Fernandez Martinez M, Landolsi S, Ferjani S, Maamar E et al (2018) Role of association of OmpK35 and OmpK36 alteration and blaESBL and\/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 52(6):898\u2013905. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4960_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jiph.2020.09.018","volume":"14","author":"S Indrajith","year":"2021","unstructured":"Indrajith S, Mukhopadhyay AK, Chowdhury G, Farraj DAA, Alkufeidy RM, Natesan S et al (2021) Molecular insights of carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples. J Infect Public Health 14(1):131\u2013138. https:\/\/doi.org\/10.1016\/j.jiph.2020.09.018","journal-title":"J Infect Public Health"},{"issue":"7","key":"4960_CR48","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/microorganisms11071690","volume":"11","author":"G Zhou","year":"2023","unstructured":"Zhou G, Wang Q, Wang Y, Wen X, Peng H, Peng R et al (2023) Outer membrane porins contribute to antimicrobial resistance in gram-negative bacteria. Microorganisms 11(7):1690. https:\/\/doi.org\/10.3390\/microorganisms11071690","journal-title":"Microorganisms"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04960-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:48:59Z","timestamp":1782744539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04960-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4960"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04960-9","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The study approval was obtained from the Research Ethics Committee of Cairo University Medical School, Cairo, Egypt (protocol number N-13-2020). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent from all subjects and\/or their legal guardian(s) was waived by Institutional Review Board of Cairo University Medical School as we used archived deidentified isolates were routinely collected for clinical diagnosis, all isolates deidentified to maintain patient privacy and kept anonymous during the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}],"article-number":"402"}}